Abstract
Although the zebrafish model provides an important platform for the study of developmental biology, recent work with the zebrafish model has extended its application to a wide variety of experimental studies relevant to human disease. Currently, the zebrafish model is used for the study of human genetic disease, caveolin-associated muscle disease, homeostasis, kidney development and disease, cancer, cardiovascular disorders, oxidative stress, caloric restriction, insulin-like pathways, angiogenesis, neurological diseases, liver disease, hemophilia, bacterial pathogenesis, apoptosis, osteoporosis, immunological studies, germ cell study, Bardet-Biedl syndrome gene (BBS11), Alzheimers disease, virology studies and vaccine development. Here we describe the essential use of the zebrafish model that applies to several clinical diseases. With increased understanding of the cellular mechanisms responsible for disease, we can use knowledge gained from the zebrafish model for the development of therapeutics.
Keywords: Zebrafish, diseases model, disease mechanism, genetic diseases, muscle disease, hemostasis, kidney disease, cancer, cardiovascular disorders, oxidative stress
Current Neurovascular Research
Title: The Zebrafish Model: Use in Studying Cellular Mechanisms for a Spectrum of Clinical Disease Entities
Volume: 4 Issue: 2
Author(s): Chi-Hsin Hsu, Zhi-Hong Wen, Chan-Shing Lin and Chiranjib Chakraborty
Affiliation:
Keywords: Zebrafish, diseases model, disease mechanism, genetic diseases, muscle disease, hemostasis, kidney disease, cancer, cardiovascular disorders, oxidative stress
Abstract: Although the zebrafish model provides an important platform for the study of developmental biology, recent work with the zebrafish model has extended its application to a wide variety of experimental studies relevant to human disease. Currently, the zebrafish model is used for the study of human genetic disease, caveolin-associated muscle disease, homeostasis, kidney development and disease, cancer, cardiovascular disorders, oxidative stress, caloric restriction, insulin-like pathways, angiogenesis, neurological diseases, liver disease, hemophilia, bacterial pathogenesis, apoptosis, osteoporosis, immunological studies, germ cell study, Bardet-Biedl syndrome gene (BBS11), Alzheimers disease, virology studies and vaccine development. Here we describe the essential use of the zebrafish model that applies to several clinical diseases. With increased understanding of the cellular mechanisms responsible for disease, we can use knowledge gained from the zebrafish model for the development of therapeutics.
Export Options
About this article
Cite this article as:
Hsu Chi-Hsin, Wen Zhi-Hong, Lin Chan-Shing and Chakraborty Chiranjib, The Zebrafish Model: Use in Studying Cellular Mechanisms for a Spectrum of Clinical Disease Entities, Current Neurovascular Research 2007; 4 (2) . https://dx.doi.org/10.2174/156720207780637234
DOI https://dx.doi.org/10.2174/156720207780637234 |
Print ISSN 1567-2026 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5739 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Interactive Effect of Combined Exposure to Active and Passive Smoking on Cardiovascular System
Recent Patents on Cardiovascular Drug Discovery Editorial [Hot Topic: PET and SPECT in Drug Evaluation and Drug Design Imaging Inflammatory Processes, Tumors, and the Endocannabinoid System(Executive Editor: Aren van Waarde)]
Current Pharmaceutical Design Clinical Presentations and Diagnosis of Brucellosis
Recent Patents on Anti-Infective Drug Discovery The Role of Reactive Species in Epileptogenesis and Influence of Antiepileptic Drug Therapy on Oxidative Stress
Current Neuropharmacology Neuropeptide Y: Role in Emotion and Alcohol Dependence
CNS & Neurological Disorders - Drug Targets Clinical and Pathophysiological Relations Between Migraine and Mood Disorders
Current Psychiatry Reviews Buccal Cell Cytokeratin 14 Identifies Mild Cognitive Impairment and Alzheimer’ s Disease in the AIBL Study of Aging
Current Alzheimer Research SNP-Mediated Neuroprotection under Glucose Deprivation Is Enhanced by Hypericum perforatum
CNS & Neurological Disorders - Drug Targets Critical Atomic-level Processing Technologies: Remote Plasma-enhanced Atomic Layer Deposition and Atomic Layer Etching
Micro and Nanosystems The I.F.A.S.T. Model Allows the Prediction of Conversion to Alzheimer Disease in Patients with Mild Cognitive Impairment with High Degree of Accuracy
Current Alzheimer Research Molecular Docking Supplements an In vitro Determination of the Leading CYP Isoform for Arylpiperazine Derivatives
Combinatorial Chemistry & High Throughput Screening Disease-Related Changes in TRPV1 Expression and Its Implications for Drug Development
Current Topics in Medicinal Chemistry The Pharmaceutical Economics of Child Psychiatric Drug Treatment
Current Pharmaceutical Design Neuroprotective Effects of Cannabidiol in Hypoxic Ischemic Insult. The Therapeutic Window in Newborn Mice
CNS & Neurological Disorders - Drug Targets Cytochromes P450 and Skin Cancer: Role of Local Endocrine Pathways
Anti-Cancer Agents in Medicinal Chemistry Receptor-Interacting Protein Kinase 1 (RIPK1) as a Potential Therapeutic Target: An Overview of Its Possible Role in the Pathogenesis of Alzheimer's Disease
Current Alzheimer Research Commentary: Research Highlights: IKKβ Mediates Aβ-Triggered Microglial Inflammation and Neuronal Death During Alzheimer's Disease
CNS & Neurological Disorders - Drug Targets Role of Androgens in Womens Sexual Function & Dysfunction: What Have We Learned in Six Decades?
Current Women`s Health Reviews Opioids in the Frame of New Psychoactive Substances Network: A Complex Pharmacological and Toxicological Issue
Current Molecular Pharmacology Discriminating Drug-Like Compounds by Partition Trees with Quantum Similarity Indices and Graph Invariants
Current Pharmaceutical Design